Improving Care

Reducing morbidity and mortality and enhancing quality of life

Informing Policy

Transforming health care at the local, national and international levels

Featured Projects

With more than 80 scientists, research at Advancing Health encompasses a wide breadth of areas


The Evidence Speaks

A recurring feature highlighting the latest in Advancing Health research

Our People

In the News

Research Resources

From design to execution, Advancing Health provides a broad range of support services

Work in Progress Seminar Series

Our People

BC and Federal governments sign $71.7 M funding agreement for innovative substance use disorder treatments

Posted on


Foundry is one of the recipients of a funding agreement signed between Canada’s Health Minister Ginette Petitpas Taylor, and BC’s Minister of Mental Health and Addictions, Judy Darcy, that recognizes the investment of over $71.7 million to enhance or increase access to quality treatment services for substance use disorder. The funding received by Foundry will go towards their efforts to provide youth health and wellness resources, services, and supports across BC. CHÉOS Scientists Drs. Steve Mathias and Skye Barbic are Foundry’s Executive Director and Research Lead, respectively.

The funding will also be directed toward expanding injectable opioid agonist treatment, supportive recovery, and initiatives that improve local-level capacity to connect individuals with appropriate treatment options among other efforts.

“With the Emergency Treatment Fund, our Government is helping to ensure that innovative and comprehensive treatment options are available for Canadians who want and need them,” said Petitpas Taylor in a news release.

Other Scientists at CHÉOS are conducting research to expand the options available for people who are seeking support for substance use disorders, including Drs. Eugenia Oviedo-Joekes, Nick Bansback, Martin SchechterMichael Krausz, Patricia Spittal, and Aslam Anis. You can read more about some of the latest CHÉOS research in substance user disorder treatment here.